FacebooklinkedinFacebooklinkedin

La lista delle pubblicazioni scientifiche che mi vedono come autore

Canonica GW; Bagnasco D; Bondi B; Varricchi G; Paoletti G; Blasi F; Paggiaro P; Braido F, 2024. SANI clinical remission definition: a useful tool in severe asthma management.  J Asthma.

Paoletti G; Buta F; Di Bona D, 2024. Editorial: pharmacotherapy and evidence-based medicine.  Curr Opin Allergy Clin Immunol 24(4):228-229

Ghelli C; Costanzo G; Canonica GW; Heffler E; Paoletti G, 2024. New evidence in food allergies treatment.  Curr Opin Allergy Clin Immunol 24(4):251-256

Pelaia C; Zannoni E; Paoletti G; Marzio V; Heffler E; Carrón-Herrero A, 2024. Clinical remission in severe asthma: lights and shadows on an ambitious goal.  Curr Opin Allergy Clin Immunol 24(4):230-236

Latorre M; Rizzi A; Paggiaro P; Baiardini I; Bagnasco D; Del Giacco S; Lombardi C; Patella V; Nucera E; Parente R; Paoletti G; Pini L; Ridolo E; Senna G; Blasi F; Canonica GW, 2024. Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients.  J Asthma.

Ordak M; Canonica GW; Paoletti G; Brussino L; Carvalho D; Di Bona D, 2024. Meta-analysis in allergy-Statistical recommendations.  Allergy 79(6):1616-1618

Di Bona D; Carlucci P; Spataro F; Paoletti G; Cognet-Sicé J; Scurati S; Canonica GW, 2024. IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies.  J Allergy Clin Immunol Glob 3(2):100208

Giombi F; Pace GM; Pirola F; Cerasuolo M; Ferreli F; Mercante G; Spriano G; Canonica GW; Heffler E; Ferri S; Puggioni F; Paoletti G; Malvezzi L, 2024. Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?  Int J Mol Sci 25.

Giombi F; Pace GM; Nappi E; Giunta G; Muci G; Pirola F; Ferreli F; Heffler E; Paoletti G; Giannitto C; Mercante G; Francone M; Spriano G; Canonica GW; Malvezzi L, 2024. Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study.  Laryngoscope 134(6):2626-2633

Ordak M; Canonica GW; Paoletti G; Brussino L; Carvalho D; Di Bona D, 2024. Statistical advice provided by ChatGPT regarding an accepted article in Allergy.  Allergy 79(3):748-751

Ferri S; Montagna C; Casini M; Malvezzi L; Pirola F; Russo E; Racca F; Messina MR; Puggioni F; Nappi E; Costanzo G; Del Moro L; Mercante G; Spriano G; Canonica GW; Paoletti G; Heffler E, 2024. Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by dupilumab.  Ann Allergy Asthma Immunol 132(1):69-75

Bagnasco D; Nicola S; Testino E; Brussino L; Pini L; Caminati M; Piccardo F; Canevari RF; Melissari L; Ioppi A; Guastini L; Lombardi C; Milanese M; Losa F; Robbiano M; De Ferrari L; Riccio AM; Guida G; Bonavia M; Fini D; Balbi F; Caruso C; Paggiaro P; Blasi F; Heffler E; Paoletti G; Canonica GW; Senna G; Passalacqua G; On Behalf Of Sani, 2023. Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.  Biomedicines 11.

Paoletti G; Costanzo G; Eigenmann P; Kalayci Ö, 2023. Editorial comment on "Environmental influences on childhood asthma: Climate change".  Pediatr Allergy Immunol 34(8):e14011

Cottini M; Bondi B; Bagnasco D; Braido F; Passalacqua G; Licini A; Lombardi C; Berti A; Comberiati P; Landi M; Heffler E; Paoletti G, 2023. Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control.  Respir Med 218:107391

Canonica GW; Varricchi G; Paoletti G; Heffler E; Virchow JC, 2023. Advancing precision medicine in asthma: Evolution of treatment outcomes.  J Allergy Clin Immunol 152(4):835-840

Paoletti G; Costanzo G; Del Moro L; Spataro F; Carlucci P; Di Bona D, 2023. Editorial: pharmacotherapy and evidence-based medicine section.  Curr Opin Allergy Clin Immunol 23(4):307-308

Canonica GW; Del Moro L; Costanzo G; Nappi E; Paoletti G, 2023. Real-world data: A relevant component in the framework of scientific evidence.  Asia Pac Allergy 13(1):40-43

Ferri S; Paoletti G; Pelaia C; Heffler E; Canonica GW; Puggioni F, 2023. COPD and biologic treatment: state of the art.  Curr Opin Allergy Clin Immunol 23(4):309-318

Costanzo G; Costanzo GAML; Del Moro L; Nappi E; Pelaia C; Puggioni F; Canonica GW; Heffler E; Paoletti G, 2023. Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line.  Int J Mol Sci 24.

Nappi E; Racca F; Piona A; Messina MR; Ferri S; Lamacchia D; Cataldo G; Costanzo G; Del Moro L; Puggioni F; Canonica GW; Heffler E; Paoletti G, 2023. Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines.  Vaccines (Basel) 11.

Messina MR; Crisciotti C; Pellegrini L; Nappi E; Racca F; Costanzo G; Del Moro L; Ferri S; Puggioni F; Canonica GW; Heffler E; Paoletti G, 2023. Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions.  Vaccines (Basel) 11.

Paoletti G; Pepys J; Bragato MC; Paoletti S; Piona A; Messina MR; Racca F; Ferri S; Nappi E; Costanzo G; Del Moro L; Puggioni F; Canonica GW; Azzolini E; Heffler E, 2023. The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital.  Vaccines (Basel) 11.

Sahiner UM; Giovannini M; Escribese MM; Paoletti G; Heffler E; Alvaro Lozano M; Barber D; Canonica GW; Pfaar O, 2023. Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation.  J Pers Med 13.

Nappi E; Keber E; Paoletti G; Casini M; Carosio C; Romano F; Floris N; Parmigiani C; Salvioni C; Malvezzi L; Puggioni F; Canonica GW; Heffler E; Giua C, 2023. Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era.  J Pers Med 13.

Pirola F; Giunta G; Muci G; Giombi F; Nappi E; Grizzi F; Heffler E; Paoletti G; Canonica GW; Mercante G; Spriano G; Schroeder JW; Malvezzi L, 2023. Evolution in Endoscopic Sinus Surgery: The Adjuvant Role of Reboot Surgery in Patients with Uncontrolled Nasal Symptoms of Eosinophilic Granulomatosis with Polyangiitis.  J Pers Med 13.

Giunta G; Pirola F; Giombi F; Muci G; Pace GM; Heffler E; Paoletti G; Puggioni F; Cerasuolo M; Ferreli F; Salamanca F; Mercante G; Spriano G; Canonica GW; Malvezzi L, 2023. Care for Patients with Type-2 Chronic Rhinosinusitis.  J Pers Med 13.

Russo E; Giombi F; Paoletti G; Heffler E; Canonica GW; Pirola F; Mercante G; Spriano G; Malvezzi L; Keber E; Sgcp; Giua C, 2023. Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist's Perceptions.  J Pers Med 13.

Ridolo E; Barone A; Nicoletta F; Paoletti G; Heffler E; Malvezzi L; Canonica GW, 2023. Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate.  Expert Rev Clin Immunol 19(6):575-584

Di Bona D; Carlucci P; Spataro F; Paoletti G; Heffler E; Pulkanen J; Macchia L; Giacco SD; Agache I; Jutel M; Schünemann HJ; Canonica GW, 2023. Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy.  Clin Exp Allergy 53(6):610-625

Guida G; Carriero V; Bertolini F; Pizzimenti S; Heffler E; Paoletti G; Ricciardolo FLM, 2023. Exhaled nitric oxide in asthma: from diagnosis to management.  Curr Opin Allergy Clin Immunol 23(1):29-35

Melone G; Giorgis V; Di Pino M; Pelaia C; Nappi E; Heffler E; Landi M; Gelardi M; Paoletti G, 2023. Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity.  Int Arch Allergy Immunol 184(1):12-20

Pirola F; Pace GM; Giombi F; Heffler E; Paoletti G; Nappi E; Sanità W; Giulietti G; Giunta G; Ferreli F; Mercante G; Spriano G; Canonica GW; Malvezzi L, 2023. Outcomes of Non-Mucosa Sparing Endoscopic Sinus Surgery (Partial Reboot) in Refractory Chronic Rhinosinusitis with Nasal Polyposis: An Academic Hospital Experience.  Laryngoscope 133(7):1584-1589

Bocciolini C; Nappi E; Giunta G; Paoletti G; Malvezzi L; Monti G; Macchi A; Amorosa L; Heffler E, 2023. Middle meatus nasal cytology compared to inferior turbinate cytology in non allergic rhinitis.  Eur Arch Otorhinolaryngol 280(2):913-918

Pirola F; Giombi F; Ferreli F; Costantino A; Mercante G; Paoletti G; Heffler E; Canonica GW; Settimi S; De Corso E; Spriano G; Malvezzi L, 2022. Cross-Cultural Validation of the Short Version of the Questionnaire of Olfactory Disorders-Negative Statements into Italian: Towards Personalized Patient Care.  J Pers Med 12.

Paoletti G; Malvezzi L; Riccio AM; Descalzi D; Pirola F; Russo E; De Ferrari L; Racca F; Ferri S; Messina MR; Puggioni F; Nappi E; Bagnasco D; Canevari FR; Grizzi F; Mercante G; Spriano G; Canonica GW; Heffler E, 2022. Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps.  World Allergy Organ J 15(11):100700

Guida G; Bagnasco D; Carriero V; Bertolini F; Ricciardolo FLM; Nicola S; Brussino L; Nappi E; Paoletti G; Canonica GW; Heffler E, 2022. Critical evaluation of asthma biomarkers in clinical practice.  Front Med (Lausanne) 9:969243

Varricchi G; Ferri S; Pepys J; Poto R; Spadaro G; Nappi E; Paoletti G; Virchow JC; Heffler E; Canonica WG, 2022. Biologics and airway remodeling in severe asthma.  Allergy 77(12):3538-3552

Ridolo E; Incorvaia C; Pucciarini F; Makri E; Paoletti G; Canonica GW, 2022. Current treatment strategies for seasonal allergic rhinitis: where are we heading?  Clin Mol Allergy 20(1):9

Paoletti G, 2022. Editorial: Pharmacotherapy and evidence based medicine.  Curr Opin Allergy Clin Immunol 22(4):257-258

Di Bona D; Spataro F; Carlucci P; Paoletti G; Canonica GW, 2022. Severe asthma and personalized approach in the choice of biologic.  Curr Opin Allergy Clin Immunol 22(4):268-275

Giombi F; Carrón-Herrero A; Pirola F; Paoletti G; Nappi E; Russo E; De Virgilio A; Mercante G; Canonica GW; Spriano G; Heffler E; Malvezzi L, 2022. Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis.  Int Forum Allergy Rhinol 12(12):1562-1565

Morandini P; Laino ME; Paoletti G; Carlucci A; Tommasini T; Angelotti G; Pepys J; Canonica GW; Heffler E; Savevski V; Puggioni F, 2022. Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas.  Clin Transl Allergy 12(6):e12144

Paoletti G; Pepys J; Casini M; Di Bona D; Heffler E; Goh CYY; Price DB; Canonica GW, 2022. Biologics in severe asthma: the role of real-world evidence from registries.  Eur Respir Rev 31.

Nappi E; De Santis M; Paoletti G; Pelaia C; Terenghi F; Pini D; Ciccarelli M; Selmi CF; Puggioni F; Canonica GW; Heffler E, 2022. New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine.  Vaccines (Basel) 10.

Ridolo E; Incorvaia C; Heffler E; Cavaliere C; Paoletti G; Canonica GW, 2022. The Present and Future of Allergen Immunotherapy in Personalized Medicine.  J Pers Med 12.

Baiardini I; Paoletti G; Mariani A; Malvezzi L; Pirola F; Spriano G; Mercante G; Puggioni F; Racca F; Melone G; Malipiero G; Ferri S; Canonica GW; Heffler E, 2022. Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps.  Healthcare (Basel) 10.

Ferri S; Crimi C; Campisi R; Cacopardo G; Paoletti G; Puggioni F; Crimi N; Heffler E, 2022. Impact of asthma on bronchiectasis severity and risk of exacerbations.  J Asthma 59(3):469-475

Racca F; Pellegatta G; Cataldo G; Vespa E; Carlani E; Pelaia C; Paoletti G; Messina MR; Nappi E; Canonica GW; Repici A; Heffler E, 2021. Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets.  Front Physiol 12:815842

Di Bona D; Paoletti G; Chu DK; Pepys J; Macchia L; Heffler E; Canonica GW, 2021. Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis.  Clin Transl Allergy 11(4):e12033

Lenti MV; Savarino E; Mauro A; Penagini R; Racca F; Ghisa M; Laserra G; Merli S; Arsiè E; Longoni V; de Bortoli N; Sostilio A; Marabotto E; Ziola S; Vanoli A; Zingone F; Barberio B; Tolone S; Docimo L; Pellegatta G; Paoletti G; Ribolsi M; Repici A; Klersy C; Di Sabatino A, 2021. Diagnostic delay and misdiagnosis in eosinophilic oesophagitis.  Dig Liver Dis 53(12):1632-1639

Paoletti G; Racca F; Piona A; Melone G; Merigo M; Puggioni F; Ferri S; Azzolini E; Lagioia M; Lamacchia D; Cataldo G; Cecconi M; Canonica GW; Heffler E, 2021. Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital.  World Allergy Organ J 14(5):100541

Heffler E; Detoraki A; Contoli M; Papi A; Paoletti G; Malipiero G; Brussino L; Crimi C; Morrone D; Padovani M; Guida G; Gerli AG; Centanni S; Senna G; Paggiaro P; Blasi F; Canonica GW, 2021. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?  Allergy 76(3):961-962

Paoletti G; Di Bona D; Chu DK; Firinu D; Heffler E; Agache I; Jutel M; Klimek L; Pfaar O; Mösges R; DunnGalvin A; Genuneit J; Hoffmann HJ; Canonica GW, 2021. Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence".  Allergy 76(9):2663-2672

Senna G; Latorre M; Bugiani M; Caminati M; Heffler E; Morrone D; Paoletti G; Parronchi P; Puggioni F; Blasi F; Canonica GW; Paggiaro P, 2021. Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI.  Allergy Asthma Immunol Res 13(2):219-228

Giua C; Paoletti G; Minerba L; Malipiero G; Melone G; Heffler E; Pistone A; Keber E, 2021. Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists.  Int J Clin Pharm 43(3):708-715

Paoletti G; Melone G; Ferri S; Puggioni F; Baiardini I; Racca F; Canonica GW; Heffler E; Malipiero G, 2021. Gastroesophageal reflux and asthma: when, how, and why.  Curr Opin Allergy Clin Immunol 21(1):52-58

Malipiero G; Melone G; Puggioni F; Pawankar R; Heffler E; Paoletti G, 2021. Allergen immunotherapy and biologics in respiratory allergy: friends or foes?  Curr Opin Allergy Clin Immunol 21(1):16-23

Pini L; Paoletti G; Heffler E; Tantucci C; Puggioni F, 2021. Alpha1-antitrypsin deficiency and asthma.  Curr Opin Allergy Clin Immunol 21(1):46-51

Malipiero G; Paoletti G; Blasi F; Paggiaro P; Senna G; Latorre M; Caminati M; Carpagnano GE; Crimi N; Spanevello A; Aliberti S; Canonica GW; Heffler E, 2021. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry.  Expert Rev Respir Med 15(3):419-424

Heffler E; Detoraki A; Contoli M; Papi A; Paoletti G; Malipiero G; Brussino L; Crimi C; Morrone D; Padovani M; Guida G; Gerli AG; Centanni S; Senna G; Paggiaro P; Blasi F; Canonica GW, 2021. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments.  Allergy 76(3):887-892

Paoletti G; Keber E; Heffler E; Malipiero G; Baiardini I; Canonica GW; Giua C, 2020. Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma.  Respir Med 174:106199

Paoletti G; Melone G; Guida G; Pirola F; Malvezzi L; Pelaia C; Mariani A; Racca F; Malipiero G; Ferri S; Puggioni F; Spriano G; Canonica GW; Heffler E, 2020. Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma.  J Breath Res 15(1):016007

Ferreli F; Gaino F; Russo E; Di Bari M; Pirola F; Costantino A; Malvezzi L; De Virgilio A; Colombo G; Paoletti G; Morenghi E; Canonica GW; Spriano G; Heffler E; Mercante G, 2020. Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis.  J Allergy Clin Immunol Pract 8(10):3587-3589

Malipiero G; Heffler E; Pelaia C; Puggioni F; Racca F; Ferri S; Spinello L; Merigo M; Lamacchia D; Cataldo G; Sansonna M; Canonica GW; Paoletti G, 2020. Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model.  Clin Transl Allergy 10:23

Bagnasco D; Brussino L; Caruso C; Paoletti G; Heffler E; Guida G; Calzolari E; Nicola S; De Ferrari L; Passalacqua G; Canonica GW, 2020. Do the current guidelines for asthma pharmacotherapy encourage over-treatment?  Expert Opin Pharmacother 21(11):1283-1286

Malipiero G; Paoletti G; Puggioni F; Racca F; Ferri S; Marsala A; Leoncini O; Porli M; Pieri G; Canonica GW; Heffler E, 2020. An academic allergy unit during COVID-19 pandemic in Italy.  J Allergy Clin Immunol 146(1):227

Heffler E; Carpagnano GE; Favero E; Guida G; Maniscalco M; Motta A; Paoletti G; Rolla G; Baraldi E; Pezzella V; Piacentini G; Nardini S, 2020. Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC).  Multidiscip Respir Med 15(1):36

Solinas A; Paoletti G; Firinu D; Di Pino M; Tusconi M; Mura JF; Del Giacco S; Marongiu F, 2020. Vaping effects on asthma: results from a web survey and clinical investigation.  Intern Emerg Med 15(4):663-671

Bagnasco D; Massolo A; Bonavia M; Brussino L; Bucca C; Caminati M; Canonica GW; Caruso C; D'Amato M; De Ferrari L; Guida G; Heffler E; Lombardi C; Menzella F; Milanese M; Paoletti G; Riccio AM; Rolla G; Senna G; Testino E; Passalacqua G, 2020. The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.  Allergy 75(6):1460-1463

Pelaia C; Paoletti G; Puggioni F; Racca F; Pelaia G; Canonica GW; Heffler E, 2019. Interleukin-5 in the Pathophysiology of Severe Asthma.  Front Physiol 10:1514

Puggioni F; Alves-Correia M; Mohamed MF; Stomeo N; Mager R; Marinoni M; Racca F; Paoletti G; Varricchi G; Giorgis V; Melioli G; Canonica GW; Heffler E, 2019. Immunostimulants in respiratory diseases: focus on Pidotimod.  Multidiscip Respir Med 14:31

Bagnasco D; Caminati M; Menzella F; Milanese M; Rolla G; Lombardi C; Bucca C; Heffler E; Paoletti G; Testino E; Manfredi A; Caruso C; Guida G; Senna G; Bonavia M; Riccio AM; Canonica GW; Passalacqua G, 2019. One year of mepolizumab. Efficacy and safety in real-life in Italy.  Pulm Pharmacol Ther 58:101836

Carlotta F; Raffaella R; Ilaria A; Alessandro N; Mannuccio MP, 2019. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients.  Eur J Intern Med 68:e7-e11

Heffler E; Paoletti G; Giorgis V; Puggioni F; Racca F; Del Giacco S; Bagnasco D; Caruso C; Brussino L; Rolla G; Canonica GW, 2019. Real-life studies of biologics used in asthma patients: key differences and similarities to trials.  Expert Rev Clin Immunol 15(9):951-958

Khalaf K; Paoletti G; Puggioni F; Racca F; De Luca F; Giorgis V; Canonica GW; Heffler E, 2019. Asthma from immune pathogenesis to precision medicine.  Semin Immunol 46:101294

Heffler E; Malvezzi L; Pirola F; Zięba N; Paoletti G; Mercante G; Spriano G; Canonica GW, 2019. Treatable traits in chronic rhinosinusitis with nasal polyps.  Curr Opin Allergy Clin Immunol 19(4):373-378

Heffler E; Brussino L; Del Giacco S; Paoletti G; Minciullo PL; Varricchi G; Scadding G; Malvezzi L; De Virgilio A; Spriano G; Puggioni F; Fornero M; Rolla G; Canonica GW, 2019. New drugs in early-stage clinical trials for allergic rhinitis.  Expert Opin Investig Drugs 28(3):267-273

Publication list retrieved from NCBI using ImpactPubs

.

FacebooklinkedininstagrammailFacebooklinkedininstagrammail